Czech health ministry recommends AstraZeneca, J&J jabs only for over-60s
The Czech health ministry recommended on Wednesday that only people over 60 years old should receive COVID-19 vaccines from AstraZeneca and Johnson & Johnson due to a potential risk of blood clots.
- Country:
- Czech Republic
The Czech health ministry recommended on Wednesday that only people over 60 years old should receive COVID-19 vaccines from AstraZeneca and Johnson & Johnson due to a potential risk of blood clots. Scientists and U.S. and European drug regulators have been searching for an explanation for what is causing rare but potentially deadly clots accompanied by low blood platelet counts, which have led some countries to halt or limit use of the AstraZeneca and J&J vaccines.
The Czech health ministry said it made the decision after responding to recommendations from the country's drug regulator SUKL and the Czech Vaccination Society. U.S., EU and other regulators have said the benefits of receiving the AstraZeneca or J&J shots outweigh any risks.
Vaccinations in the country of 10.7 million have accelerated in recent weeks with Pfizer's two-dose jab making up the majority of supply in the central European nation.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Health News Roundup: Pfizer RSV shot meets goals in trial of high-risk adults under age 60; Cuba says drug use on the rise, especially among youth and more
GLOBAL MARKETS-Asian shares fall on U.S. rate scare, yen plumbs 34-yr low
EMERGING MARKETS-Stocks, FX slide after U.S. inflation print triggers global selloff
GLOBAL MARKETS-Europe turns to ECB after U.S. inflation selloff
Russia and U.S. are in contact over non-deployment of nuclear weapons in space - TASS